> Details

Nowrousian, Mohammad R.; Brandhorst, Dieter; Sammet, Christiane; Kellert, Michaela; Daniels, Rainer; Schuett, Philipp; Poser, Miriam; Mueller, Siemke; Ebeling, Peter; Welt, Anja; Bradwell, Arthur R.; Buttkereit, Ulrike; Opalka, Bertram; Flasshove, Michael; Moritz, Thomas; Seeber, Siegfried

Serum Free Light Chain Analysis and Urine Immunofixation Electrophoresis in Patients with Multiple Myeloma

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Serum Free Light Chain Analysis and Urine Immunofixation Electrophoresis in Patients with Multiple Myeloma
  • Contributor: Nowrousian, Mohammad R.; Brandhorst, Dieter; Sammet, Christiane; Kellert, Michaela; Daniels, Rainer; Schuett, Philipp; Poser, Miriam; Mueller, Siemke; Ebeling, Peter; Welt, Anja; Bradwell, Arthur R.; Buttkereit, Ulrike; Opalka, Bertram; Flasshove, Michael; Moritz, Thomas; Seeber, Siegfried
  • imprint: American Association for Cancer Research (AACR), 2005
  • Published in: Clinical Cancer Research
  • Language: English
  • DOI: 10.1158/1078-0432.ccr-05-0486
  • ISSN: 1078-0432; 1557-3265
  • Keywords: Cancer Research ; Oncology
  • Origination:
  • Footnote:
  • Description: <jats:title>Abstract</jats:title> <jats:p>Purpose: Retrospective studies have shown that immunoassays measuring free light chains (FLC) in serum are useful for diagnosis and monitoring of multiple myeloma. This study prospectively evaluates the use of FLC assays and, for the first time, investigates the relationship between serum FLC concentrations and the presence and detectability of Bence Jones (BJ) proteins in the urine.</jats:p> <jats:p>Patients and Methods: Three hundred seventy-eight paired samples of serum and urine were tested from 82 patients during the course of their disease. The sensitivities of serum FLC analysis and urine immunofixation electrophoresis (IFE) in detecting monoclonal FLC were compared. Serum FLC concentrations required for producing BJ proteins detected by IFE were determined.</jats:p> <jats:p>Results: Abnormal FLC were present in 54% of serum samples compared with 25% by urine tests. In abnormal serum samples for κ or λ, the sensitivity of IFE to detect the respective BJ proteins in urine were 51% and 35% and the median serum FLC concentrations required to produce detectable BJ proteins were 113 and 278 mg/L. Renal excretions of monoclonal FLC increased with serum concentrations, but excretions significantly decreased at high serum concentrations combined with renal dysfunction.</jats:p> <jats:p>Conclusion: Serum FLC assays are significantly more sensitive for detecting monoclonal FLC than urine IFE analysis. They also have the advantage of FLC quantification and are more reliable for monitoring disease course and response to treatment.</jats:p>
  • Access State: Open Access